Some regions of the brain in people with Alzheimer’s reorganise more often while at rest than in people without the disease, and in healthy people this...
Researchers have found that both low and moderate-high intensity exercise could be valuable tools in the fight against Alzheimer’s. The new research describes the results of...
Hydromethylthionine mesylate (HMTM) could potentially be the first oral treatment for Alzheimer’s disease (AD) that targets the tau protein pathology – if it is approved by...
We round up the latest agetech research spanning diabetes, Alzheimer’s, heart disease, eye health and beyond. Yo-yo dieting may significantly increase kidney disease risk in people...
Deep sleep may wash away waste buildup in the brain during waking hours, an essential process for maintaining brain health, new research has found. The findings...
A team of researchers has discovered a surprising link between a chronic gut infection caused by a common virus and the development of Alzheimer’s disease in...
The Medicines and Healthcare products Regulatory Agency (MHRA) has today, 23 October 2024, approved a licence for the medicine donanemab (Kisunla) for use in the early...
Higher levels of HDL-C—known as the “good cholesterol”—have been shown to correlate with heightened risk for Alzheimer’s disease. A new study, published in the Journal of...
An international team of researchers has made a promising breakthrough in the development of drugs to treat Alzheimer’s Disease. For the first time, scientists have developed...
Scientists at The University of Texas Health Science Center at San Antonio (UT Health San Antonio) have reported the largest-ever genome-wide association study of dementia from...
